Companies in #Autoimmune disease
Found 2 companies operating in this sector.
HCW Biologics is a clinical-stage biopharmaceutical company developing novel immunotherapies for chronic, low-grade inflammation and related diseases. Its pipeline includes HCW9302, an injectable IL-2 fusion protein complex in clinical trials for alopecia areata; HCW11-018b, a tetra-valent T-cell engager; and multifunctional fusion molecules combining cytokines with checkpoint blockade. The company also develops reagents for NK-cell and CAR-therapy production under licensing arrangements with partners such as Wugen and WY Biotech.
Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing autologous and allogeneic CAR T-cell therapies for autoimmune diseases. Kyverna is poised to become the first company to file a regulatory application for a CAR T-cell therapy in autoimmune disease.